ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,311Medicare Part D Prescriptions Filled, Including Refills

Rank: 212 out of 1024

$496K Total Retail Price of All Prescriptions

Rank: 256 out of 1024

232 Patients Receiving at Least One Drug in Part D
81% Patients 65 Years and Older
89% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Connecticut
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

13% of this provider’s 232 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

N/A

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $68 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
FUROSEMIDE 284 271 41 1 6
LISINOPRIL 258 215 47 2 4
AMLODIPINE BESYLATE 256 229 35 3 3
METOPROLOL TARTRATE 245 224 43 4 7
WARFARIN SODIUM 244 205 20 5 8
SIMVASTATIN 238 224 41 6 5
TRAZODONE HCL 201 196* 33 7 22
ATORVASTATIN CALCIUM 194 157 37 8 1
LEVOTHYROXINE SODIUM 191 134 28 9 2
OMEPRAZOLE 188 162 37 10 9
CYMBALTA 165 134 18 11 35
DIOVAN 155 150* 20 12 21
MIRTAZAPINE 131 126* 25 13 31
GABAPENTIN 130 125* 27 14 18
ESCITALOPRAM OXALATE 124 110 20 15 14
TAMSULOSIN HCL 106 101* 24 16 24
DONEPEZIL HCL 105 105 19 17 25
METFORMIN HCL 100 80 19 18 10
CLOPIDOGREL 99 79 16 19 28
RISPERIDONE 90 76 14 A 20 48
POTASSIUM CHLORIDE 88 59 12 21 30
QUETIAPINE FUMARATE 79 61 13 A 22 44
ZOLPIDEM TARTRATE 79 74* 18 22 19
LANTUS 78 73* 19 24 53
CITALOPRAM HBR 77 72* 17 25 37
SERTRALINE HCL 70 <11 <11 26 23
MONTELUKAST SODIUM 68 <11 <11 27 46
LORAZEPAM 67 56 14 B 28 26
CARVEDILOL 67 62* 12 28 40
METOPROLOL SUCCINATE 67 62* 16 28 12
ZETIA 65 <11 <11 31 52
ATENOLOL 65 <11 <11 31 13
NAMENDA 64 <11 <11 33 27
TRAMADOL HCL 63 58* 20 34 36
GEMFIBROZIL 62 <11 <11 35 170
DIVALPROEX SODIUM 62 <11 <11 35 59
IPRATROPIUM-ALBUTEROL 61 56* 23 37 80
HUMALOG 59 35 13 38 123
RAMIPRIL 57 <11 <11 39 86
LOSARTAN POTASSIUM 54 49* 14 40 16
ABILIFY 54 <11 <11 A 40 77
LIDODERM 53 48* 11 42 69
PREDNISONE 51 51 16 43 38
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 27, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.